{
    "2020-07-22": [
        [
            {
                "time": "2023-10-15",
                "original_text": "AbbVie's Rinvoq Meets Late-Stage Eczema Study Endpoints",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rinvoq",
                        "Late-Stage",
                        "Eczema",
                        "Study Endpoints"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Is AbbVie a Great Dividend Stock?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dividend",
                        "Stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}